Strive purchased 124 Bitcoin for about $10 million at an average price of $80,526 per coin, increasing its total holdings to 43,124 BTC. This acquisition marks the first use of its $1 billion SATS preferred stock ATM program, diversifying its funding sources beyond cash. Strive aims to balance Bitcoin accumulation with shareholder value by managing financing costs and capital structure. The company is now the fourth-largest public Bitcoin holder, pursuing its goal to become the second-largest while navigating financing challenges.
Strive's recent Bitcoin purchase provides context for cryptocurrency market activity on Pluang. For readers following digital assets, here is Pluang's market snapshot as of Nov 02, 2026 22:01 WIB: out of 50 major cryptocurrencies priced, 6 rose and 43 fell. Notable movers include GRT at Rp358 with a 1-day change of -3.04% and a typical hold time of 99 days, and EGLD at Rp60,788 with a 1-day change of -3.02%.
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
